Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 237,283,990 papers from all fields of science
Search
Sign In
Create Free Account
ALK Inhibitor X-396
Known as:
Anaplastic Lymphoma Kinase Inhibitor X-396
, X-396
An orally available small molecule inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with potential antineoplastic activity…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Receptor Tyrosine Kinase Inhibition
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Abstract 2622: New therapeutic strategies in neuroblastoma: combined targeting of a novel tyrosine kinase inhibitor and liposomal siRNAs againstALK
D. Paolo
,
L. Emionite
,
+8 authors
P. Perri
2014
Corpus ID: 70484701
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA The anaplastic lymphoma kinase (ALK), a tyrosine kinase…
Expand
2011
2011
Therapeutics , Targets , and Chemical Biology Insights into ALK-Driven Cancers Revealed through Development of Novel ALK Tyrosine Kinase Inhibitors
C. Lovly
,
J. Heuckmann
,
+4 authors
W. Pao
2011
Corpus ID: 31131847
Aberrant forms of the anaplastic lymphoma kinase (ALK) have been implicated in the pathogenesis of multiple human cancers, where…
Expand